Skip to content
Dr. Mwangi

Dr. Mwangi

The Insurance Scheme Strategist

A Chief Medical Officer at a private health insurer. She watches NCD claims grow unsustainably and has no prevention lever upstream of diagnosis.

The claims spreadsheet, last Tuesday

Dr. Mwangi opens the monthly claims summary and scrolls to the NCD tab. The numbers are worse than last month. They are always worse than last month. SHA collected KES 57.7B in 2024/25 but paid out KES 91.5B in claims. The deficit is structural, not seasonal. SHA faces a KES 116B funding shortfall overall. The private insurers Dr. Mwangi works with see the same pattern at smaller scale.

She highlights the cost-per-patient rows. Hypertension management: KES 7,458-13,149 per year per patient in out-of-pocket costs alone. Diabetes management: KES 53,907 per year. Dialysis: KES 960,000 per year. These are not one-time claims. They are annuities. Once a diagnosis lands, the claim stream continues indefinitely. A single diabetes patient costs the scheme more per year than fifty healthy policyholders pay in premiums.

NCD claims are the fastest-growing category on her spreadsheet. They are growing faster than premium income. The ratio is unsustainable without intervention upstream of diagnosis. But Dr. Mwangi has no upstream lever. Insurers pay for treatment after diagnosis. They fund medications, hospitalizations, lab work, specialist visits. They have no mechanism to intervene in the daily meals where NCD risk is actually created.

She has funded wellness programs. Annual checkups. Health talks at corporate clients. A walking challenge with a leaderboard. These are marketing exercises. They generate goodwill, not cost reduction. None of them has ever reduced a single claim. Meanwhile, Kenya's flour fortification since 2012 adds iron, zinc, folate, B12, and vitamin A to every bag of maize and wheat flour -- but the universal habit of consuming that flour as ugali with chai means tannins and phytates block 80-90% of the fortified iron from being absorbed. The government's investment in fortification is leaking away at the dinner table. The cheapest dietary interventions -- a tomato with beans at KES 5, lemon on stew at KES 5, oil on greens at KES 3 -- cost less than any supplement program and work within existing food culture. She closes the spreadsheet and opens a blank slide. The board meets on Friday. She needs a strategy that works before the claim, not after.

SHA collected KES 57.7B in 2024/25 but paid out KES 91.5B in claims.

You have run these numbers

You have watched NCD claims grow faster than premium income, quarter after quarter. You have funded wellness programs that generate satisfaction surveys but never reduce claims. You have no lever upstream of diagnosis -- no tool, no product, no intervention that reaches policyholders in the meals where risk is actually created.

You are not missing ambition. You are missing a tool that works before the claim.

Now run the numbers with prevention

10,000 policyholders x KES 40/month x 12 = KES 4,800,000 per year. That is the cost. If 50 NCD diagnoses are delayed or prevented in that population: 50 x KES 150,000 average annual treatment cost = KES 7,500,000 per year saved. Return: 1.6x in year one.

The return compounds. Every year a diagnosis is delayed is another year the claim stream does not start. Every policyholder whose nutritional completeness score rises is a policyholder whose risk profile improves -- not on a questionnaire, but in what their body absorbs from the food they eat every day.

A tool that works upstream of the claim, at the meal level, where NCD risk is actually created. Not a wellness program. A cost-reduction instrument with measurable outcomes.